Literature DB >> 25390739

High-cost generic drugs--implications for patients and policymakers.

Jonathan D Alpern1, William M Stauffer, Aaron S Kesselheim.   

Abstract

Some older generic drugs have become very expensive, owing to factors including drug shortages, supply disruptions, and consolidations in the generic-drug industry. But generics manufacturers that legally obtain a market monopoly can also unilaterally raise prices.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25390739     DOI： 10.1056/NEJMp1408376

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


  28 in total

1.  A Novel, Highly Sensitive Quantitative Polymerase Chain Reaction Assay for the Diagnosis of Subarachnoid and Ventricular Neurocysticercosis and for Assessing Responses to Treatment.

Authors:  Elise M O'Connell; Sarah Harrison; Eric Dahlstrom; Theodore Nash; Thomas B Nutman
Journal:  Clin Infect Dis       Date:  2020-04-15       Impact factor: 9.079

2.  The introduction of generic aromatase inhibitors and treatment adherence among Medicare D enrollees.

Authors:  Joan M Neuner; Sailaja Kamaraju; John A Charlson; Erica M Wozniak; Elizabeth C Smith; Alana Biggers; Alicia J Smallwood; Purushottam W Laud; Liliana E Pezzin
Journal:  J Natl Cancer Inst       Date:  2015-05-12       Impact factor: 13.506

3.  Expediting Formulary Standardization in a Multihospital Health System Using Layered Learners.

Authors:  Amanda J Hays; Jennifer R Smith; Rebecca M Guth; Susan E Samet
Journal:  P T       Date:  2018-03

4.  The Impact of Off-Patent Drug Acquisitions on Prices.

Authors:  Ravi Gupta; Alexis Henkel; Howard P Forman; Joseph S Ross
Journal:  J Gen Intern Med       Date:  2018-07       Impact factor: 5.128

5.  Medicare Part D Payments for Topical Steroids: Rising Costs and Potential Savings.

Authors:  Hannah Song; Adewole Adamson; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2017-08-01       Impact factor: 10.282

Review 6.  Value in Colorectal Cancer Treatment: Where It Is Lacking, and Why.

Authors:  Leonard B Saltz
Journal:  Cancer J       Date:  2016 May-Jun       Impact factor: 3.360

7.  FOUR FACTS CONCERNING COMPETITION IN U.S. GENERIC PRESCRIPTION DRUG MARKETS.

Authors:  Rena M Conti; Ernst R Berndt
Journal:  Int J Econ Bus       Date:  2019-09-05

8.  Responsibilities, Strategies, and Practice Factors in Clinical Cost Conversations: a US Physician Survey.

Authors:  Rahma Warsame; Lindsay Riordan; Sarah Jenkins; Kandace Lackore; Joel Pacyna; Ryan Antiel; Timothy Beebe; Mark Liebow; Bjorg Thorsteinsdottir; Michael Grover; Matthew Wynia; Susan Dorr Goold; Matthew DeCamp; Marion Danis; Jon Tilburt
Journal:  J Gen Intern Med       Date:  2020-05-12       Impact factor: 5.128

9.  Absence of Loa loa Microfilaremia among Newly Arrived Congolese Refugees in Texas.

Authors:  Jessica Montour; Deborah Lee; Cathy Snider; Emily S Jentes; William Stauffer
Journal:  Am J Trop Med Hyg       Date:  2017-08-31       Impact factor: 2.345

10.  Trends in Pricing and Generic Competition Within the Oral Antibiotic Drug Market in the United States.

Authors:  Jonathan D Alpern; Lei Zhang; William M Stauffer; Aaron S Kesselheim
Journal:  Clin Infect Dis       Date:  2017-11-13       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.